How Long Does Wegovy Take to Work?

1. How Wegovy starts working (days 1-7)

Wegovy is semaglutide, a GLP-1 receptor agonist. The first injection begins binding to GLP-1 receptors in your gut, brain, and pancreas within hours. By day 3-5, most patients notice the earliest signs: portions feeling larger than usual, fewer intrusive thoughts about food (often called “food noise”), and meals becoming satisfying with less volume.

These early effects are pharmacologic, not weight-related. The scale typically won't move in the first week — and if it does, it's usually water-weight from reduced sodium intake or glycogen depletion as you eat less. Real fat loss takes a sustained calorie deficit, which the appetite reduction enables but doesn't guarantee.

What patients commonly report in week 1:

• Reduced hunger between meals (the most consistent early sign)
• Earlier fullness — half a normal portion satisfies
• Mild nausea, especially the day after injection (peaks day 1-2 of each new dose)
• Constipation or changes in stool pattern as gastric emptying slows
• Increased thirst (drink 2-3L water daily during titration)

2. Week-by-week timeline (full)

The standard Wegovy titration takes 16 weeks to reach the 2.4mg maintenance dose. Each step lasts 4 weeks minimum. STEP-1 trial cohort averages at each timepoint:

The plateau pattern is consistent across the GLP-1 class: most weight loss happens in months 2-12, with the remaining loss tapering through months 12-18. Individual variation is wide — some patients hit their personal plateau at 8% loss, others at 25%+.

3. When side effects peak (and resolve)

Side effects follow a predictable arc tied to dose changes. Each new dose typically triggers a 1-2 week wave of nausea, fatigue, and GI symptoms, which then subside as the body adapts. Visualizing this helps set expectations:

The takeaway: each dose increase is a small reset. Plan demanding weeks (work travel, big events) around the “adaptation window” — typically weeks 1-2 after a dose change. By week 3-4 of each step, most patients feel close to baseline. For comprehensive management of each symptom, see our symptom guides.

4. What affects your specific timeline

Trial averages mask wide individual variation. Factors that accelerate or slow your timeline:

Factors associated with faster loss

• Higher starting BMI — heavier patients lose more absolute weight and often higher percentage
• Protein-first eating — preserves lean mass, supports satiety
• Resistance training 2-3×/week — preserves muscle, raises resting metabolism
• Consistent injection day — stable serum levels
• Sleep 7-9 hours — affects appetite hormones and metabolic rate

Factors associated with slower loss

• Liquid-calorie habits — smoothies, alcohol, juice bypass appetite suppression
• Very low protein intake — drives muscle loss + slower metabolism
• Sedentary lifestyle — lower baseline energy expenditure
• Sleep deprivation — elevates ghrelin, reduces leptin
• Concurrent steroid use — promotes weight gain pharmacologically
• Hypothyroidism, PCOS, Cushing's — endocrine conditions affecting metabolism

The biggest single lever is protein. STEP-1 didn't prescribe a target, but cohort analyses suggest patients meeting 0.7-1g protein per pound of goal weight preserved more lean mass and had higher long-term success.

5. If Wegovy isn't working by month 3

Approximately 10-15% of patients respond minimally to Wegovy even with proper titration and lifestyle support — sometimes called “non-responders.” If you've completed at least 12 weeks (reached 1.0mg) and lost less than 3% body weight:

1. Audit liquid calories. Smoothies, lattes, alcohol, and juices can add 600-1200 cal/day that bypass appetite suppression entirely.
2. Track protein for 1 week. Most patients underestimate by 30-50g daily. Target 0.7-1g per pound goal weight.
3. Discuss accelerated titration with prescriber. Some patients respond at 2.4mg who didn't at 1.0-1.7mg.
4. Rule out endocrine causes. Thyroid panel, cortisol screening, sex-hormone panel where relevant.
5. Consider switching to Zepbound. About 30-40% of semaglutide non-responders respond to tirzepatide due to the dual GIP/GLP-1 mechanism. See Wegovy vs Zepbound for transition planning.

6. Plateaus and when to expect them

Three predictable plateau windows during Wegovy treatment:

• Week 8-12 plateau: The 0.5-1.0mg transition often coincides with a 1-2 week pause as body adapts. Don't increase dose pre-emptively.
• Week 30-40 plateau: Common 4-6 week pause mid-treatment. Usually breaks if you maintain protein + lifestyle. Resist switching protocols.
• Final plateau (week 60-68): Body reaches new equilibrium. STEP-5 showed this can be maintained with continued treatment.

The hardest plateau to manage is the final one — it's not a problem to solve, it's the destination. Setting expectation for an 11-18% personal plateau (vs trial-averaged 15%) prevents frustration in months 12-18.

7. Sustaining weight loss long-term

The STEP-4 trial answered a critical question: what happens when you stop Wegovy? Patients who stopped after 20 weeks regained roughly two-thirds of their lost weight by week 68 of follow-up. STEP-5 confirmed that continued treatment maintained weight at week 104.

Implications:

• Plan for ongoing treatment, similar to chronic disease medications (e.g., statins for cholesterol)
• Some patients successfully maintain at lower maintenance doses (1.7mg instead of 2.4mg) — discuss with prescriber after stabilizing
• If stopping is necessary (cost, pregnancy planning, side effects), expect gradual regain — not failure, but pharmacology returning to baseline
• Combining Wegovy with structured lifestyle support (registered dietitian, exercise programming) improves long-term adherence and outcomes

8. Frequently asked questions

How long does it take to feel Wegovy working?

Most patients notice reduced hunger within 3-7 days of their first injection — this is the appetite-suppression effect, not weight loss. Visible weight loss typically begins around week 5, with measurable changes (1-2% body weight) often appearing by week 4 on the scale. The full appetite-control effect strengthens through weeks 8-16 as the dose escalates from 0.25mg to the 2.4mg maintenance.

How much weight will I lose in the first month of Wegovy?

Average first-month weight loss on Wegovy is approximately 2% of starting body weight at the 0.25mg starter dose, based on STEP-1 trial cohort data. For a 200-pound starting weight, that's roughly 4 pounds in the first 4 weeks. Individual results vary substantially — some patients lose 1-2% in month 1, others 4-5%. The starter dose is intentionally low to minimize side effects, not to maximize early loss.

When does Wegovy stop working?

Wegovy doesn't lose pharmacologic effect — it continues to suppress appetite as long as you take it at the right dose. However, weight loss plateaus by about week 60-68 in most patients as the body reaches a new equilibrium. The STEP-5 trial showed sustained weight maintenance through week 104 with continued treatment. Stopping Wegovy typically leads to regain of about two-thirds of lost weight within 12 months (STEP-4 trial).

Why am I not losing weight on Wegovy after 3 months?

Common reasons for slow response by month 3: still at low titration doses (0.25 or 0.5mg), eating high-calorie liquid foods that bypass appetite suppression, very sedentary lifestyle reducing energy expenditure, medication interactions, or being a "non-responder" (roughly 10-15% of patients per STEP-1). Discuss with your prescriber — they may accelerate titration or evaluate other factors. Don't self-adjust dose.

Can I lose weight faster on Wegovy?

The titration schedule (4 weeks at each dose) is designed to minimize GI side effects, not to slow progress. Some prescribers accelerate titration in patients tolerating well, but skipping steps significantly raises nausea/vomiting risk. The bigger lever for "faster loss" is dietary discipline + protein intake + resistance exercise during the titration weeks, not racing through the dose schedule.

How long until I reach my goal weight on Wegovy?

Average weight loss at the 2.4mg maintenance dose was 14.9% over 68 weeks in STEP-1. To reach a 15% goal from a 200-pound starting weight (30 pounds), most patients need about 14-16 months of treatment. The new 7.2mg dose option (FDA-approved expansion) achieved 18.7% average loss in extension trials. Faster pace is possible but not consistently — set expectations around the trial-averaged 14-16 month window.

• Editorial board reviewed
• CC BY 4.0 data
• FDA-source citations
• Affiliate disclosed

Timeline data sourced from STEP-1 (NCT03548935), STEP-4, STEP-5, and FDA prescribing label. Individual results vary substantially. GLP1Zoom is affiliate-disclosed and does not prescribe or sell Wegovy. Always discuss timing, dose, and expectations with your prescriber. Full disclaimer.